Loading data for MIRA — first visit, this takes a few seconds.
MIRA Pharmaceuticals Inc. (MIRA)
NasdaqCM: MIRA
· Real-Time Price · USD
0.76
+0.03 (4.11%)
At close: Aug 28, 2026, 3:26 PM
0.75
+0.00%
After-hours: 6:28 PM
The price, the headline numbers and the latest news, in one place.
MIRA Pharmaceuticals Inc. (MIRA) Stock Price, Analysis & Data
4.11% (1D)
| Bid | 0.57 |
| Market Cap | 31.52M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -31.04M |
| 1.55 | |
| -1.19 | |
| n/a | |
| -1.83 | |
| P/B (ttm) | 3.87 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 0.95 |
| Volume | 116,711 |
| Avg. Volume (20D) | 100,040 |
| Open | 0.72 |
| Previous Close | 0.73 |
| Day's Range | 0.72 - 0.81 |
| 52-Week Range | 0.60 - 2.45 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MIRA
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treatin...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Aug 3, 2023
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol MIRA
Website https://mirapharmaceuticals.com
Financial Performance
In 2025, MIRA Pharmaceuticals's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -10.44M, an increase of 32.98%.
Financial StatementsEarnings Surprise
MIRA Pharmaceuticals has released their quarterly earnings on Nov 13, 2025:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.07 exceeds estimates by 0.01, with 50.00% YoY growth.
